Deepika Arora
Rheumatology · League City, TXNPI 1053689455
Payments from drug & device makers
Across 857 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$3K
- Johnson & Johnson$1K
- AstraZeneca$1K
- Novartis$1K
- UCB, Inc.$1K
- plus $7K from 33 others
What the payments were for
- Food & beverage$17,33896%
- Education$2171%
- Other$5203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 201 | $3,338 |
| Amgen(2 entities) | 128 | $2,947 |
| Johnson & Johnson(2 entities) | 72 | $1,381 |
| AstraZeneca(2 entities) | 50 | $1,151 |
| Novartis | 54 | $1,117 |
| UCB, Inc. | 45 | $1,097 |
| Pfizer | 34 | $789 |
| GSK | 41 | $765 |
| Lilly USA, LLC | 39 | $722 |
| Mallinckrodt Hospital Products Inc. | 30 | $720 |
| Aurinia Pharma U.S., Inc. | 24 | $566 |
| Welch Allyn | 1 | $520 |
| Sanofi | 15 | $343 |
| E.r. Squibb & Sons, L.L.C. | 24 | $342 |
| ANI Pharmaceuticals, Inc. | 16 | $310 |
| Sanofi-aventis U.S. LLC | 3 | $182 |
| Genentech USA, Inc. | 9 | $166 |
| Organon | 8 | $163 |
| Fresenius Kabi USA, LLC | 7 | $154 |
| Sobi, Inc | 6 | $152 |
| Teva Pharmaceuticals USA, Inc. | 7 | $124 |
| Hikma Pharmaceuticals USA | 5 | $104 |
| Octapharma USA, Inc. | 1 | $97 |
| Radius Health, Inc. | 5 | $91 |
| Almatica Pharma LLC | 4 | $85 |
| Boehringer Ingelheim | 4 | $81 |
| Tersera Therapeutics LLC | 2 | $71 |
| Fidia Pharma USA Inc. | 5 | $67 |
| Sandoz | 2 | $57 |
| Invivyd Inc | 2 | $56 |
| Mallinckrodt Enterprises LLC | 2 | $51 |
| Novo Nordisk | 1 | $50 |
| Kyowa Kirin, Inc. | 2 | $45 |
| Ultragenyx Pharmaceutical Inc. | 2 | $43 |
| Merck | 2 | $41 |
| Biocon Biologics Inc | 1 | $28 |
| Bristol Myers Squibb | 1 | $23 |
| Mylan Institutional Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$520
- Tavneos$273
- Tremfya$125
- SIMPONI ARIA$125
How this compares
$18,075 in reported general payments places this provider in the 65th percentile of 512 rheumatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 35 | $278,801 |
| Xeljanz XrTofacitinib Citrate | 12 | $64,639 |
| Hydroxychloroquine Sulfate | 112 | $4,024 |
| MethotrexateMethotrexate Sodium | 64 | $1,555 |
| Leflunomide | 12 | $1,402 |
| Duloxetine Hcl | 20 | $559 |
| Gabapentin | 33 | $426 |
| Sulfasalazine DrSulfasalazine | 16 | $331 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 11 | $307 |
| Folic Acid | 12 | $226 |
| Methylprednisolone | 21 | $208 |
| Prednisone | 28 | $149 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in League City
- Paul PickrellAustin$40.9M
- Atul SinghalMesquite$13.9M
- Shaikh AliTomball$9.8M
- Jitendra VasandaniLubbock$6.4M
- Dhiman BasuColleyville$6.2M
- Tamar BrionezThe Woodlands$5.2M
- Philip WallerHouston$4.9M
- John CushDallas$3.9M
- Sabeen NajamBaytown$3.6M
- Sanjay ChabraEl Paso$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.